Statistics
Publications
16
Citations
1.6K
H-Index
15
Active since
2011
Hengrui Zhu is an author at The Wistar Institute specializing in oncology, medicine, and molecular oncology.
Publications per year
2011–2025
16
16
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu, Fee Bengsch, Nikolaos Svoronos et al. · Cell Reports · 2016 · 431 citations · Full text
Medicine, Immunology, Oncology +17
BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
Sergey Karakashev, Hengrui Zhu, Yuhki Yokoyama et al. · Cell Reports · 2017 · 174 citations · Full text
SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells
Tom L. Stephen, Kyle K. Payne, Ricardo A. Chaurio et al. · Immunity · 2017 · 158 citations · Full text
1–5 of 16